Trial Profile
Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Pioglitazone (Primary)
- Indications Diabetes mellitus; Insulin resistance
- Focus Therapeutic Use
- Acronyms RAMP
- 30 Nov 2017 Status changed from recruiting to completed.
- 26 Oct 2016 Status changed from not yet recruiting to recruiting.
- 14 Apr 2016 New trial record